Fleury S.A. - Asset Resilience Ratio

Latest as of June 2026: 13.87%

Fleury S.A. (FLRY3) has an Asset Resilience Ratio of 13.87% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fleury S.A. (FLRY3) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

R$1.88 Billion
≈ $368.90 Million USD Cash + Short-term Investments

Total Assets

R$13.56 Billion
≈ $2.66 Billion USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Fleury S.A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Fleury S.A..

Liquid Assets Composition Over Time

This chart breaks down Fleury S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore FLRY3 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents R$0.00 0%
Short-term Investments R$1.88 Billion 13.87%
Total Liquid Assets R$1.88 Billion 13.87%

Asset Resilience Insights

  • Moderate Liquidity: Fleury S.A. has 13.87% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

Fleury S.A. Industry Peers by Asset Resilience Ratio

Compare Fleury S.A.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Chemclin Diagnostics Co. Ltd. A
SHG:688468
Diagnostics & Research 15.34%
Monash Ivf Group Ltd
AU:MVF
Diagnostics & Research 1.60%
Healius Ltd
AU:HLS
Diagnostics & Research 0.06%
Scope Fluidics SA
WAR:SCP
Diagnostics & Research 16.51%
RHYTHM Biosciences Ltd
AU:RHY
Diagnostics & Research 2.74%
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
Diagnostics & Research 0.14%
Sonic Healthcare Ltd
AU:SHL
Diagnostics & Research 0.13%
Integral Diagnostics Ltd
AU:IDX
Diagnostics & Research 0.03%

Annual Asset Resilience Ratio for Fleury S.A. (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Fleury S.A..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 16.19% R$2.14 Billion
≈ $420.03 Million
R$13.22 Billion
≈ $2.59 Billion
-1.57pp
2024-12-31 17.76% R$2.32 Billion
≈ $455.22 Million
R$13.06 Billion
≈ $2.56 Billion
+9.97pp
2023-12-31 7.79% R$902.21 Million
≈ $177.03 Million
R$11.58 Billion
≈ $2.27 Billion
-8.79pp
2022-12-31 16.58% R$1.29 Billion
≈ $253.56 Million
R$7.79 Billion
≈ $1.53 Billion
+3.92pp
2021-12-31 12.67% R$769.39 Million
≈ $150.97 Million
R$6.07 Billion
≈ $1.19 Billion
-5.78pp
2020-12-31 18.45% R$1.02 Billion
≈ $199.61 Million
R$5.51 Billion
≈ $1.08 Billion
+2.83pp
2019-12-31 15.62% R$795.89 Million
≈ $156.17 Million
R$5.10 Billion
≈ $1.00 Billion
-4.96pp
2018-12-31 20.57% R$804.49 Million
≈ $157.85 Million
R$3.91 Billion
≈ $767.30 Million
+1.56pp
2017-12-31 19.01% R$670.57 Million
≈ $131.58 Million
R$3.53 Billion
≈ $692.13 Million
+5.59pp
2016-12-31 13.42% R$403.47 Million
≈ $79.17 Million
R$3.01 Billion
≈ $589.80 Million
+13.28pp
2015-12-31 0.15% R$4.70 Million
≈ $922.81K
R$3.20 Billion
≈ $628.73 Million
+1.13pp
2014-12-31 -0.98% R$-31.46 Million
≈ $-6.17 Million
R$3.21 Billion
≈ $629.81 Million
-0.58pp
2013-12-31 -0.40% R$-12.97 Million
≈ $-2.54 Million
R$3.21 Billion
≈ $630.09 Million
-0.01pp
2012-12-31 -0.40% R$-10.86 Million
≈ $-2.13 Million
R$2.74 Billion
≈ $537.28 Million
-0.41pp
2011-12-31 0.02% R$434.00K
≈ $85.16K
R$2.83 Billion
≈ $555.63 Million
+0.01pp
2010-12-31 0.00% R$19.00K
≈ $3.73K
R$1.33 Billion
≈ $260.61 Million
+1.36pp
2009-12-31 -1.36% R$-17.07 Million
≈ $-3.35 Million
R$1.26 Billion
≈ $246.48 Million
+2.93pp
2008-12-31 -4.29% R$-26.44 Million
≈ $-5.19 Million
R$616.76 Million
≈ $121.02 Million
-2.36pp
2007-12-31 -1.93% R$-9.75 Million
≈ $-1.91 Million
R$505.94 Million
≈ $99.27 Million
+5.58pp
2006-12-31 -7.51% R$-24.48 Million
≈ $-4.80 Million
R$326.11 Million
≈ $63.99 Million
--
pp = percentage points

About Fleury S.A.

SA:FLRY3 Brazil Diagnostics & Research
Market Cap
$2.32 Billion
R$11.82 Billion BRL
Market Cap Rank
#5665 Global
#65 in Brazil
Share Price
R$21.74
Change (1 day)
-1.18%
52-Week Range
R$14.20 - R$22.11
All Time High
R$26.18
About

Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medi… Read more